Startups
Virtual Therapeutics Corp.
Kirkland, Washington, United States
Virtual Therapeutics Corporation is a privately held digital-health company incorporated in Delaware on May29,2015 and based in Kirkland, Washington. Its current vthera.com website describes immersive mental-health and mental-fitness products: Breakthrough combines interactive media, intelligent real-time feedback and AI-based analysis, while Bloom is its virtual-reality experience for stress, anxiety, resilience and sleep. Its ADHD cognitive-medicine products EndeavorRx and EndeavorOTC are developed by acquired subsidiary Akili; the parent completed Akili’s take-private acquisition on July2,2024. This acquisition at USD0.434 per Akili share was a purchase of existing securities, not a new financing round for either issuer. The May31,2024 primary SEC tender filing states that Polaris Partners and ClavystBio completed separate non-controlling minority equity investments in Virtual Therapeutics on May24,2024, for undisclosed amounts. Founder Daniel J. Elenbaas retained majority shareholder control; the two institutional investors jointly appointed one director. The four named officers/directors in that filing are last-confirmed2024 appointments rather than an asserted complete2026 roster. Its March2024 own employee interview identifies VR software engineer Bhavya Mandali. The current home page publishes no complete named staff directory. An older own biography page includes unfinished placeholder text and partial names; these are excluded from a current staff claim. This exact Delaware corporation and vthera.com domain are distinct from virtualtherapeutics.com and other similarly named therapeutics businesses. Healthcare and technology partnerships do not establish investment participation. No private fund, funding total or acquisition-funded cash allocation is inferred.
Founded 2015
Team
Ben WiegandIndependent Director (last confirmed May2024) |
 Bhavya MandaliVR Software Engineer (reported March2024) |
 Daniel J ElenbaasFounder, President, CEO and Director (last confirmed May2024) |
 Marissa BertorelliDirector (last confirmed May2024) |
Matt McIntireVice President, Operations and Finance (last confirmed May2024) |